Mustang Bio, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Clinical Trial and Sponsored Research Agreements (Tables)

Clinical Trial and Sponsored Research Agreements (Tables)

6 Months Ended

Jun. 30, 2023

Sponsored Research and Clinical Trial Agreements [Member]

License, Clinical Trial and Sponsored Research Agreements

Schedule of Clinical Trial and Sponsored Research Agreements

For the three and six months ended June 30, 2023, and 2022, the Company recorded the following expense in research and development for sponsored research and clinical trial agreements in the Unaudited Statements of Operations pursuant to the terms of this agreement:


	For the three months ended June 30,				For the six months ended June 30,
($ in thousands)	2023		2022		2023		2022
City of Hope National Medical Center
CD123	$	—	$	52	$	—	$	103
IL13Rα2		326		234		636		462
CS1		139		50		188		100
HER2		—		271		—		542
PSCA		22		28		44		50
Fred Hutchinson Cancer Center - CD20		544		358		1,098		846
St. Jude Children's Research Hospital - XSCID		216		94		634		218
LUMC - RAG1 SCID		112		138		224		265
Mayo Clinic		275		231		551		462
Total	$	1,634	$	1,456	$	3,375	$	3,048